The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126912491 12691249 1 I 20160116 20160816 20160826 20160826 EXP FR-MYLANLABS-2016M1035199 MYLAN 0.00 Y 0.00000 20160826 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126912491 12691249 1 SS METHYLPREDNISOLONE MYLAN METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 100 MG, UNK 0 100 MG
126912491 12691249 2 PS METHOTREXATE. METHOTREXATE 1 Intrathecal UNK 201529 INJECTION
126912491 12691249 3 SS ETOPOSIDE TEVA ETOPOSIDE 1 Intravenous (not otherwise specified) 190 MG, UNK 0 190 MG
126912491 12691249 4 SS CORTANCYL PREDNISONE 1 Oral 115 MG, UNK 0 115 MG
126912491 12691249 5 SS VINCRISTINE HOSPIRA VINCRISTINE 1 Intravenous (not otherwise specified) 2 MG, UNK 0 2 MG SOLUTION FOR INJECTION
126912491 12691249 6 SS ENDOXAN /00021101/ CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 1450 MG, UNK 0 1450 MG
126912491 12691249 7 SS DOXORUBICINE TEVA DOXORUBICIN 1 Intravenous (not otherwise specified) 97 MG, UNK 0 97 MG SOLUTION FOR INJECTION
126912491 12691249 8 C ONDANSETRON ACCORD ONDANSETRON 1 Intravenous (not otherwise specified) 8 MG, UNK 0 8 MG SOLUTION FOR INJECTION
126912491 12691249 9 C GRANOCYTE LENOGRASTIM 1 UNK 0 INJECTION
126912491 12691249 10 C ZELITREX VALACYCLOVIR HYDROCHLORIDE 1 Oral 500 MG, BID 0 500 MG BID
126912491 12691249 11 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0
126912491 12691249 12 C LEDERFOLINE LEUCOVORIN CALCIUM 1 Oral 25 MG, QW 0 25 MG /wk
126912491 12691249 13 C ZYLORIC ALLOPURINOL 1 Oral 100 MG, UNK 0 100 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126912491 12691249 1 Chemotherapy
126912491 12691249 2 Chemotherapy
126912491 12691249 3 Chemotherapy
126912491 12691249 4 Chemotherapy
126912491 12691249 5 Chemotherapy
126912491 12691249 6 Chemotherapy
126912491 12691249 7 Chemotherapy
126912491 12691249 8 Product used for unknown indication
126912491 12691249 9 Product used for unknown indication
126912491 12691249 10 Prophylaxis
126912491 12691249 11 Prophylaxis
126912491 12691249 12 Prophylaxis
126912491 12691249 13 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
126912491 12691249 DE
126912491 12691249 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126912491 12691249 Acute prerenal failure
126912491 12691249 Febrile bone marrow aplasia
126912491 12691249 Septic shock

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126912491 12691249 1 20160106 20160108 0
126912491 12691249 2 20160106 20160106 0
126912491 12691249 3 20160107 20160108 0
126912491 12691249 4 20160109 20160110 0
126912491 12691249 5 20160106 20160106 0
126912491 12691249 6 20160106 20160106 0
126912491 12691249 7 20160106 20160106 0
126912491 12691249 8 20160106 20160108 0
126912491 12691249 9 20160111 20160117 0